Published in Am Heart J on April 01, 1996
Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest (2003) 2.48
Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice. Circulation (2010) 1.11
Oxidized low-density lipoprotein. Methods Mol Biol (2010) 1.10
Atherosclerosis. Ann Rheum Dis (2002) 0.82
The autoantibody repertoire against copper- or macrophage-modified LDL differs in normolipidemics and hypercholesterolemic patients. J Clin Immunol (2004) 0.79
Natural Antibodies as Rheostats for Susceptibility to Chronic Diseases in the Aged. Front Immunol (2016) 0.76
Effects of fluvastatin on plasma levels of low-density lipoprotein subfractions, oxidized low-density lipoprotein, and soluble adhesion molecules: a twenty-four-week, open-label, dose-increasing study. Curr Ther Res Clin Exp (2003) 0.75
The immunology of atherosclerosis. Nat Rev Nephrol (2017) 0.75
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med (1983) 8.26
The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med (1978) 7.17
A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors. Nature (1987) 3.00
Measurement of left ventricular wall thickness and mass by echocardiography. Circulation (1972) 2.61
Reorganizing an academic medical service: impact on cost, quality, patient satisfaction, and education. JAMA (1998) 2.53
Improved outcome for prehospital cardiopulmonary collapse with resuscitation by bystanders. Circulation (1977) 2.12
Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res (2001) 2.09
Health service use among low-risk newborns after early discharge with and without nurse home visiting. J Am Board Fam Pract (1997) 1.97
Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med (1979) 1.87
Lymphomatoid Granulomatosis. Prospective clinical and therapeutic experience over 10 years. N Engl J Med (1982) 1.83
Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell (1990) 1.80
Activation of the SAPK pathway by the human STE20 homologue germinal centre kinase. Nature (1995) 1.79
A new immunodeficiency disorder in humans involving NK cells. Nature (1980) 1.78
Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000. JAMA (1991) 1.77
NIH conference. Recent advances in chronic granulomatous disease. Ann Intern Med (1983) 1.76
Severity of coronary artery disease in black and white male veterans and likelihood of revascularization. Am Heart J (2000) 1.76
Wall stress in the normal and hypertrophied human left ventricle. Am J Cardiol (1968) 1.75
Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA (1999) 1.72
Ischemic and pharmacological preconditioning in Girardi cells and C2C12 myotubes induce mitochondrial uncoupling. Circ Res (2001) 1.71
Time to presentation with acute myocardial infarction in the elderly: associations with race, sex, and socioeconomic characteristics. Circulation (2000) 1.59
Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol (1992) 1.56
Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells. J Clin Invest (1988) 1.56
Cardiac tamponade as a late complication of open heart surgery. Am Heart J (1968) 1.54
Campylobacter-like organisms in chronic gastritis, peptic ulcer, and gastric carcinoma. Scand J Gastroenterol (1987) 1.54
Ventricular volume studies in a patient with hypertrophic subaortic stenosis. Circulation (1966) 1.49
The effect of cyclosporine on the use of hospital resources for kidney transplantation. N Engl J Med (1989) 1.49
Spontaneous and diffuse coronary artery spasm unresponsive to conventional intracoronary pharmacological therapy: a case report. Catheter Cardiovasc Interv (2000) 1.48
Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes. J Clin Invest (1980) 1.43
Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function. J Exp Med (1980) 1.41
Correlation of angiographic estimates of myocardial infarct size and accumulated release of creatine kinase MB isoenzyme in man. Circulation (1977) 1.38
The North American Conference of GI Fellows: medicine and the pharmaceutical industry at its best. Am J Gastroenterol (1994) 1.38
Mechanisms of human cell-mediated cytotoxicity. III. Dependence of natural killing on microtubule and microfilament integrity. J Immunol (1982) 1.37
The relationship between fibromyalgia and interstitial cystitis. J Psychiatr Res (1997) 1.37
Test-retest performance of a mailed version of the Medical Outcomes Study 36-Item Short-Form Health Survey among older adults. Med Care (1996) 1.36
Noninvasive detection of coronary artery patency using continuous ST-segment monitoring. Am J Cardiol (1986) 1.34
Regional left ventricular performance in the year following myocardial infarction. Circulation (1972) 1.34
Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2011) 1.26
Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis. Clin Exp Immunol (1978) 1.25
Diet therapy for rheumatoid arthritis. Arthritis Rheum (1983) 1.21
Work disability among adults with asthma. Chest (1993) 1.20
Relation of graded exercise test findings after myocardial infarction to extent of coronary artery disease and left ventricular dysfunction. Am J Cardiol (1978) 1.20
Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction. Am Heart J (1981) 1.20
Determination of left ventricular preload and afterload by quantitative echocardiography in man. Circ Res (1974) 1.19
Human blood monocytes: characterization of negatively selected human monocytes and their suspension cell culture derivatives. Scand J Immunol (1981) 1.19
Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction. Am J Cardiol (1976) 1.18
Left ventricular dimensions and dynamics of filling in patients with gallop heart sounds. Am J Med (1971) 1.16
Comparison of calculations of left ventricular wall stress in man from thin-walled and thick-walled ellipsoidal models. Circ Res (1969) 1.13
Limited exercise testing soon after myocardial infarction. Correlation with early coronary and left ventricular angiography. Ann Intern Med (1981) 1.13
Increased risk of neisserial infections in systemic lupus erythematosus. Semin Arthritis Rheum (1990) 1.11
Quantitative evaluation of left ventricular function by radiographic techniques. Circulation (1976) 1.10
Bradycardia is associated with development of coronary collateral vessels in humans. Coron Artery Dis (2000) 1.09
Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event. J Immunol (1982) 1.09
Immunoregulation in infection caused by Mycobacterium tuberculosis: the presence of suppressor monocytes and the alteration of subpopulations of T lymphocytes. J Infect Dis (1979) 1.08
Platelet mitochondrial dysfunction is evident in type 2 diabetes in association with modifications of mitochondrial anti-oxidant stress proteins. Exp Clin Endocrinol Diabetes (2011) 1.08
The precordial honk. Am J Cardiol (1966) 1.07
Cardiac tamponade with nonhemorrhagic pericardial fluid complicating Dressler's syndrome. Chest (1977) 1.07
Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. Cardiovasc Res (2000) 1.07
Effects of increasing left ventricular filling. Pressure in patients with acute myocardial infarction. J Clin Invest (1970) 1.05
Autologous and allogeneic intercellular interactions: modulation by adherent cells, irradiation, and in vitro and in vivo corticosteroids. J Immunol (1979) 1.04
QT-interval prolongation, paroxysmal ventricular arrhythmias, and convulsive syncope. Ann Intern Med (1971) 1.04
Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women. Am J Cardiol (1991) 1.03
Alteration of T-lymphocyte subpopulations in sarcoidosis. Clin Immunol Immunopathol (1978) 1.03
Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis. Arthritis Rheum (2009) 1.03
Mechanisms of human cell-mediated cytotoxicity. I. Modulation of natural killer cell activity by cyclic nucleotides. J Immunol (1982) 1.02
Association of Wegener's granulomatosis with HLA-B8. Clin Immunol Immunopathol (1979) 1.02
Scleroderma esophagus: a nonspecific entity. Ann Intern Med (1984) 1.02
Left ventricular chamber volume, mass, and function in severe coronary artery disease. Circulation (1970) 1.02
Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model. Circulation (1994) 1.02
Early surgical treatment of valvular endocarditis. JAMA (1967) 1.02
Role of thyroid hormone in postnatal circulatory and metabolic adjustments. J Clin Invest (1984) 1.01
Clinical effects of glucose-insulin-potassium on left ventricular function in acute myocardial infarction: results from a randomized clinical trial. Am Heart J (1981) 1.01
Left ventricular size and function and heart size in the year following myocardial infarction. Circulation (1974) 1.00
Hemodynamic evaluation of left ventricular function in shock complicating myocardial infarction. Circulation (1972) 1.00
Coronary anatomy and arteriography in patients with unstable angina pectoris. Am J Cardiol (1978) 0.98
Griffonia simplicifolia I: fluorescent tracer for microcirculatory vessels in nonperfused thin muscles and sectioned muscle. Microvasc Res (1988) 0.98
Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery. J Am Coll Cardiol (1993) 0.97
Rheumatoid vasculitis: experience with 13 patients and review of the literature. Semin Arthritis Rheum (1985) 0.97
Resource use and quality of care for Medicare patients with acute myocardial infarction in Maryland and the District of Columbia: analysis of data from the Cooperative Cardiovascular Project. Am Heart J (1998) 0.97
Rheumatoid-like arthritis presenting as idiopathic pulmonary hemosiderosis: a report and review of the literature. J Rheumatol (1986) 0.97
Left ventricular function and hypertrophy in cardiomyopathy with depressed ejection fraction. Circulation (1973) 0.96
Aortic stenosis, angina pectoris, coronary artery disease. Cathet Cardiovasc Diagn (1976) 0.96
Psychiatric consultation in the nursing home. A survey of six states. Am J Geriatr Psychiatry (1998) 0.96
Identification of high risk subsets of acute myocardial infarction. Derived from the myocardial infarction research units cooperative study data bank. Am J Cardiol (1978) 0.96
Right ventricular infarction and function. Am Heart J (1981) 0.95
Detection of residual jeopardized myocardium 3 weeks after myocardial infarction by exercise testing with thallium-201 myocardial scintigraphy. Circulation (1980) 0.95
Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. J Mol Cell Cardiol (2000) 0.95
Are pressure ulcers preventable? A survey of experts. Adv Skin Wound Care (2002) 0.95
Left ventricular dysfunction following acute myocardial infarction. A clinicopathologic and hemodynamic profile of shock and failure. Am J Med (1973) 0.95
Quantitative coronary arteriography. Coronary anatomy of patients with unstable angina pectoris reexamined 1 year after optimal medical therapy. Am J Cardiol (1979) 0.95
Relationship between echocardiography, cardiac output, and abnormally contracting segments in patients with ischemic heart disease. Circulation (1975) 0.94
Use of an electronic stimulator for the treatment of dry mouth. J Oral Maxillofac Surg (1986) 0.94
Evidence for endothelial dysfunction and enhanced vasoconstriction in myocardial bridges. Am Heart J (1991) 0.94
Left ventricular end-diastolic pressure in chronic heart disease. Am J Med (1970) 0.94
Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction. Am J Cardiol (1982) 0.94
Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion. Am Heart J (1976) 0.94
Ventricular arrhythmias during reperfusion. Am Heart J (1986) 0.93
Coronary artery disease in women. Risk factors, evaluation, treatment, and prevention. Arch Intern Med (1993) 0.92
Allelic constitution of the hemoglobin beta chain in wild populations of the house mouse, Mus musculus. Biochem Genet (1985) 0.92
Acute effects of glucose-insulin-potassium infusion on myocardial substrates, coronary blood flow and oxygen consumption in man. Am J Cardiol (1977) 0.91